Stock Evaluator: Humana Inc. (HUM)

Humana Inc. HUM

$363.86 -2.80 -0.76%
July 31, 2026 4:03:06 PM EST November 10, 2021 Volume: 1,454,610
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Commentary & Analysis


Financial Summary

Share Statistics HUM Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $43,692.4 $1,742.7 92%
Shares Out (Mil) 121.1 76.7 66%
Institutional Ownership 99.9% 89.7% 96%
Float (Mil) 119.8 49.4 65%
Beta 0.72 0.82 42%
Avg Daily Volume (000s) 1,593 521 78%
Price Change
(52-week)
39.2% 78.7% 75%
Growth HUM Industry
Median
Percentile
(All Stocks)
Sales (5yr) 10.9% 11.0% 62%
Net Income (5yr) (18.8%) (0.7%) 21%
EPS (5yr) (17.2%) 3.1% 16
Dividends (5yr) 7.2% 0.0% 95%
Cash Flow (5yr) 28.6% (18.0%) 85%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 18 26 26
Current EPS ($0.990) $9.137 $16.482
Month Ago EPS ($0.170) $8.844 $15.733
# Rev Up 2 1 0
# Rev Down 0 0 1
Three Months Ago EPS ($0.098) $8.824 $15.233
Year/Year Chg (117.3%) (7.1%) 174.6%
Financials HUM Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $145,679 $1,456 99%
Net Income (TTM) (Mil) $1,279 $12 89%
EPS (TTM) $10.636 $0.300 95%
Operating Cash Flow (TTM) (Mil) $2,539 $138 90%
Net Cash Flow (TTM) (Mil) $2,853 $8 98%
Long-Term Debt (Q1) (Mil) $12,125 $316 93%
Enterprise Value (Q1) (Mil) $51,944 $2,170 92%
Valuation HUM Industry
Median
Percentile
(All Stocks)
P/B 2.27 2.85 55%
P/E 34.4 26.7 73%
Dividend Yield 1.0% 0.0% 67%
PEG (5yr hist) na 1.1 na
Ratios HUM Industry
Median
Percentile
(All Stocks)
Gross Margin 13.7% 27.8% 13%
Net Margin 0.9% 1.1% 34%
ROA 2.4% 1.8% 58%
ROE 6.8% 7.1% 48%
Liabilities to Assets 66.3% 59.9% 61%
F-Score 6 5 69%

Humana Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors